Paper Details 
Original Abstract of the Article :
Nizatidine (Axid) is the newest of four histamine receptor antagonists approved by the Food and Drug Administration for treatment of duodenal ulcer and maintenance therapy. It is as effective as the other histamine blockers in healing active duodenal ulcers and in the prevention of relapse. Nizatidi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2564655

データ提供:米国国立医学図書館(NLM)

A Camel's Take on Duodenal Ulcer Treatment: The Rise of Nizatidine

This research delves into the realm of duodenal ulcer treatment, exploring the effectiveness of nizatidine, a histamine receptor antagonist, compared to other histamine blockers. The study found that nizatidine is as effective as other histamine blockers in healing active duodenal ulcers and preventing relapses. Additionally, it highlights the favorable features of nizatidine, such as its comparable price to cimetidine, lack of interference with the hepatic metabolism of other drugs, and absence of significant central nervous system side effects. The researchers also emphasize the safety of nizatidine for elderly patients and those with renal insufficiency, albeit with dosage adjustments. This research sheds light on the potential benefits of nizatidine as a viable treatment option for duodenal ulcers.

The Camel's Perspective: A New Oasis in Duodenal Ulcer Treatment

This research provides a valuable perspective on duodenal ulcer treatment, showcasing the efficacy and safety of nizatidine. The study's findings highlight the potential of nizatidine to offer a cost-effective and well-tolerated treatment option for patients with duodenal ulcers. It's like finding a refreshing oasis in the vast desert of digestive health challenges.

The Camel's Perspective: A New Oasis in Duodenal Ulcer Treatment

This research emphasizes the importance of finding effective and well-tolerated treatment options for common health conditions. The study's focus on nizatidine highlights the ongoing search for better solutions to improve patient outcomes. It's a reminder that scientific inquiry continues to unveil new possibilities, offering hope for those seeking relief from health challenges.

Dr.Camel's Conclusion

This research suggests that nizatidine is an effective and well-tolerated histamine receptor antagonist for the treatment of duodenal ulcers. Its favorable features, including its effectiveness, price, and safety profile, make it a promising treatment option for patients seeking relief from this common gastrointestinal condition.
Date :
  1. Date Completed 1989-05-05
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2564655

DOI: Digital Object Identifier

2564655

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.